Fund Details
BrightEdge Ventures
Overview
Investment portfolio
7rounds
| NAME | DATE | SIZE | |
|---|---|---|---|
CellCentric | May 2026Participated | $220 MSeries D | |
Predicta Biosciences | Oct 2025Participated | $23 MSeries A | |
Mercy BioAnalytics | Sep 2025Participated | $59 MSeries B | |
Catena Biosciences | May 2024Participated | $2 MSeed | |
Mercy BioAnalytics | Apr 2023Participated | $41 MSeries A | |
Freenome | Dec 2021Participated | $300 MSeries D | |
Lunit | Nov 2021Participated | $61 MOther Equity | |
CellCentric | May 2026Participated | $220 MSeries D | |
Predicta Biosciences | Oct 2025Participated | $23 MSeries A | |
Mercy BioAnalytics | Sep 2025Participated | $59 MSeries B | |
Catena Biosciences | May 2024Participated | $2 MSeed | |
Mercy BioAnalytics | Apr 2023Participated | $41 MSeries A | |
Freenome | Dec 2021Participated | $300 MSeries D | |
Lunit | Nov 2021Participated | $61 MOther Equity |
7 Items
7
Items
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Seed | 0 | 1 |
| Series A | 0 | 2 |
| Series B | 0 | 1 |
| Series C+ | 0 | 2 |
| Other Equity | 0 | 1 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| Nov '21 | 1 |
| Dec '21 | 1 |
| Jan '22 | 0 |
| Feb '22 | 0 |
| Mar '22 | 0 |
| Apr '22 | 0 |
| May '22 | 0 |
| Jun '22 | 0 |
| Jul '22 | 0 |
| Aug '22 | 0 |
| Sep '22 | 0 |
| Oct '22 | 0 |
| Nov '22 | 0 |
| Dec '22 | 0 |
| Jan '23 | 0 |
| Feb '23 | 0 |
| Mar '23 | 0 |
| Apr '23 | 1 |
| May '23 | 0 |
| Jun '23 | 0 |
| Jul '23 | 0 |
| Aug '23 | 0 |
| Sep '23 | 0 |
| Oct '23 | 0 |
| Nov '23 | 0 |
| Dec '23 | 0 |
| Jan '24 | 0 |
| Feb '24 | 0 |
| Mar '24 | 0 |
| Apr '24 | 0 |
| May '24 | 1 |
| Jun '24 | 0 |
| Jul '24 | 0 |
| Aug '24 | 0 |
| Sep '24 | 0 |
| Oct '24 | 0 |
| Nov '24 | 0 |
| Dec '24 | 0 |
| Jan '25 | 0 |
| Feb '25 | 0 |
| Mar '25 | 0 |
| Apr '25 | 0 |
| May '25 | 0 |
| Jun '25 | 0 |
| Jul '25 | 0 |
| Aug '25 | 0 |
| Sep '25 | 1 |
| Oct '25 | 1 |
| Nov '25 | 0 |
| Dec '25 | 0 |
| Jan '26 | 0 |
| Feb '26 | 0 |
| Mar '26 | 0 |
| Apr '26 | 0 |
| May '26 | 1 |
| Jun '26 | 0 |
| Jul '26 | 0 |
| Aug '26 | 0 |
| Sep '26 | 0 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 7 |
| Enterprise Software | 1 |
| AI & Machine Learning | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 1 |
| $5M-$10M | 0 |
| $10M-$25M | 1 |
| $25M-$50M | 1 |
| $50M-$100M | 2 |
| $100M-$250M | 1 |
| $250M-$500M | 1 |
| $500M-$1B | 0 |
| $1B+ | 0 |
Deals By Geography
Top 3 of 3 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| United States | 5 |
| South Korea | 1 |
| Europe | 1 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| Bruker | 2 |
| Fidelity Management & Research Company | 2 |
| HBM Healthcare Investments | 2 |
| iSelect Fund | 2 |
| Labcorp | 2 |
| RA Capital Management | 2 |
| Sozo Ventures | 2 |
| Andreessen Horowitz | 1 |
| ArrowMark Partners | 1 |
| ARTIS Ventures | 1 |
| Avego Bioscience Capital | 1 |
| Avestria Ventures | 1 |
| Bain Capital Life Sciences | 1 |
| Binney Street Capital | 1 |
| Broadway Angels | 1 |
| Byers Capital | 1 |
| Caffeinated Capital | 1 |
| California Innovation Fund | 1 |
| Casdin Capital | 1 |
| Catalio Capital Management | 1 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 0 | 0% |
| Participating | 7 | 100% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 0 | 0% |
| Co-led | 0 | 0% |
Lead dynamics requires at least one led deal in this range
Team
Lucas de Breed
Director